BIOMATHEMATICAL APPROACHES TO CANCER
癌症的生物数学方法
基本信息
- 批准号:2007718
- 负责人:
- 金额:$ 17.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-03-01 至 2001-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from applicant's abstract): The focus of this research
will be on development of quantitative methods based on sound biological
principles for the analyses of intermediate lesions on the carcinogenic
pathway. Such lesions commonly arise in experimental carcinogenesis model
systems, such as the mouse skin and rodent liver initiation-promotion
systems. The ultimate goal of the analyses is the estimation of critical
biological parameters such as the rate of initiation and the rates of cell
division and death of initiated cells. Additionally, biologically-based
quantitative analyses should lead to the generation of hypotheses to be
tested in future experiments. The classical initiation-promotion
experimental models, namely the mouse skin and the rodent liver systems,
provide unique challenges to the analyst. In the rodent liver system,
quantitative observations on three-dimensional objects, the altered hepatic
foci, are made in two-dimensional sections under the microscope.
Stereological methods must then be employed in order to reconstruct the
three-dimensional picture. In the mouse skin system, premalignant lesions,
the papillomas, and malignant lesions are directly visible without having to
sacrifice the animal. Thus repeated observations are made on the same
animal. This leads to the statistical problem of correlated longitudinal
observations.
The two-mutation clonal expansion model of carcinogenesis will form the
basis of this work. This model, which postulates two rate-limiting steps on
the pathway to malignancy and explicitly considers cell division and cell
death, has natural interpretation within the
initiation-promotion-progression paradigm of chemical carcinogenesis. The
first rate-limiting event is identified with initiation, the clonal
expansion of initiated cells with promotion, and the second rate-limiting
event with progression. Four specific projects are planned. The first
project has to do with incorporation of more realistic biological
assumptions than have hitherto been used into the two-mutation clonal
expansion model. In particular, more realistic mathematical descriptions of
cell proliferation kinetics will be investigated. The second project will
attempt to relax the strong stereological assumptions that have been made in
the analyses of altered hepatic foci. Specifically, the assumption that
these foci are perfect spheres will be relaxed. This will allow the
application of the two-mutation model to experimental systems, such as the
kidney and the pancreas, in which the assumption of spherical foci is
untenable. The third project will develop quantitative methods for the
analyses of very small altered hepatic foci, which are now being
experimentally investigated with the development of the appropriate markers.
The fourth project will develop methods for the application of the
two-mutation clonal expansion model to the analyses of correlated
longitudinal data on intermediate lesions, such as the papillomas arising in
mouse skin painting experiments.
描述(改编自申请人摘要):本研究的重点
将是基于健全的生物定量方法的发展
致癌物质中间病变分析原则
通路 这种病变通常出现在实验性癌变模型中
系统,如小鼠皮肤和啮齿动物肝脏启动促进
系统. 分析的最终目标是估计关键的
生物学参数如起始速率和细胞增殖速率
细胞的分裂和死亡。 此外,基于生物
定量分析应导致假设的产生,
在未来的实验中测试。 经典的启蒙-促进
实验模型,即小鼠皮肤和啮齿动物肝脏系统,
给分析师带来了独特的挑战。 在啮齿动物的肝脏系统中,
对三维物体的定量观察,改变的肝脏
焦点,在显微镜下制成二维切片。
因此,必须采用体视学方法,
三维图像。 在小鼠皮肤系统中,癌前病变,
乳头状瘤和恶性病变是直接可见的,而不必
牺牲动物。 因此,重复的观察是在同一
动物 这导致了相关纵向的统计问题,
意见。
癌发生的两突变克隆扩张模型将形成
这项工作的基础。 该模型假设了两个限速步骤,
恶性肿瘤的途径,并明确考虑细胞分裂和细胞
死亡,有自然的解释,
化学致癌的启动-促进-进展模式。 的
第一个限速事件被鉴定为起始,克隆
启动细胞的扩增与促进,和第二限速
事件进展。 计划实施四个具体项目。 第一
该项目与更现实的生物融合有关
假设比迄今已被用于两个突变克隆
扩展模型 特别是,更现实的数学描述,
将研究细胞增殖动力学。 第二个项目是
试图放松强立体的假设,已在
改变的肝病灶的分析。 具体来说,假设
这些焦点是完美的球体将被松弛。 这将允许
两个突变模型的应用实验系统,如
肾脏和胰腺,其中假设球形病灶是
站不住脚 第三个项目将制定量化方法,
分析非常小的改变肝病灶,目前正在
通过开发适当的标记物进行实验研究。
第四个项目将制定应用
两突变克隆扩展模型对相关分析
中间病变的纵向数据,如乳头状瘤,
小鼠皮肤绘画实验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SURESH H MOOLGAVKAR其他文献
SURESH H MOOLGAVKAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SURESH H MOOLGAVKAR', 18)}}的其他基金
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6545083 - 财政年份:2002
- 资助金额:
$ 17.05万 - 项目类别:
Stochastic models for radiation carcinogenesis: tempora*
辐射致癌的随机模型:tempora*
- 批准号:
6592904 - 财政年份:2002
- 资助金额:
$ 17.05万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6799971 - 财政年份:2002
- 资助金额:
$ 17.05万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6950039 - 财政年份:2002
- 资助金额:
$ 17.05万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6656866 - 财政年份:2002
- 资助金额:
$ 17.05万 - 项目类别:
Stochastic models for radiation carcinogenesis: tempora*
辐射致癌的随机模型:tempora*
- 批准号:
6773839 - 财政年份:2002
- 资助金额:
$ 17.05万 - 项目类别:
相似海外基金
The role of cell cycle regulator Cdh1 in carcinogenesis and development of gastrointestinal cancer.
细胞周期调节因子Cdh1在胃肠癌发生和发展中的作用。
- 批准号:
23590980 - 财政年份:2011
- 资助金额:
$ 17.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanism of carcinogenesis by dysregulation of cell cycle via abnormal ubiquitin-mediated proteolysis
异常泛素介导的蛋白水解作用导致细胞周期失调的致癌机制
- 批准号:
23689074 - 财政年份:2011
- 资助金额:
$ 17.05万 - 项目类别:
Grant-in-Aid for Young Scientists (A)
Mechanisms of accumulation of G1-S phase cell cycle regulating protein in bladder carcinogenesis for the development of novel intarvesical treatment modalities to bladder cancer
G1-S期细胞周期调节蛋白在膀胱癌发生过程中积累的机制,用于开发膀胱癌新型膀胱内治疗方式
- 批准号:
19890113 - 财政年份:2007
- 资助金额:
$ 17.05万 - 项目类别:
Grant-in-Aid for Young Scientists (Start-up)
c-myb regulates stem-progenitor cell cycle entry in colonic crypts providing insights into colo-rectal carcinogenesis
c-myb 调节结肠隐窝中的干祖细胞周期进入,为结肠直肠癌发生提供见解
- 批准号:
nhmrc : 400216 - 财政年份:2006
- 资助金额:
$ 17.05万 - 项目类别:
NHMRC Project Grants
p12CDK2-AP1 in Cell Cycle Control & Oral Carcinogenesis
p12CDK2-AP1 在细胞周期控制中的作用
- 批准号:
6769440 - 财政年份:2003
- 资助金额:
$ 17.05万 - 项目类别:
p12CDK2-AP1 in Cell Cycle Control & Oral Carcinogenesis
p12CDK2-AP1 在细胞周期控制中的作用
- 批准号:
6679210 - 财政年份:2003
- 资助金额:
$ 17.05万 - 项目类别:
p12CDK2-AP1 in Cell Cycle Control & Oral Carcinogenesis
p12CDK2-AP1 在细胞周期控制中的作用
- 批准号:
6868884 - 财政年份:2003
- 资助金额:
$ 17.05万 - 项目类别:
p12CDK2-AP1 in Cell Cycle Control & Oral Carcinogenesis
p12CDK2-AP1 在细胞周期控制中的作用
- 批准号:
7034547 - 财政年份:2003
- 资助金额:
$ 17.05万 - 项目类别:
p12CDK2-AP1 in Cell Cycle Control & Oral Carcinogenesis
p12CDK2-AP1 在细胞周期控制中的作用
- 批准号:
6816786 - 财政年份:2003
- 资助金额:
$ 17.05万 - 项目类别:
Cell cycle transactivation factor E2F-4 is associate with the ganstrointestinal carcinogenesis and/or acquisition of chemoresistance
细胞周期反式激活因子E2F-4与胃肠癌发生和/或化疗耐药性的获得有关
- 批准号:
11671237 - 财政年份:1999
- 资助金额:
$ 17.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)